joachim von pawel, germany randomized phase 3 trial of amrubicin versus topotecan
Published 12 years ago • 278 plays • Length 10:52Download video MP4
Download video MP3
Similar videos
-
3:13
javelin bladder 100: duration of treatment-free interval
-
1:56
palmares-2: comparing first-line palbociclib, ribociclib, or abemaciclib in hr /her2- abc
-
3:22
immunotherapy for parkinson disease developed by eu funded project sympath
-
7:04
time to call the pathologist by dr. giuseppe argenziano
-
2:05
what happens in the brain
-
7:26
walzerfolge (waltz) no.2 aus der rosenkavalier, trv 227a (2024 remastered, amsterdam 1960)
-
59:00
pl engres all hands february 2023 (ipfs, filecoin, libp2p ipld)
-
14:15
exploration profile: multilingualism of time
-
20:44
beutler symposium | guy ledergor, phd (prof. ido amit)
-
2:01
extended time-lapse ivm of real time multicellualr dynamics of tumor | protocol preview
-
1:28
two americans, one german win nobel prize for medicine
-
11:25
andreas günther - the european ipf registry and biobank
-
0:46
using neuroimaging to track inflammation in alzheimer’s disease
-
1:09
neurophysiology and neuroimaging of pnes
-
1:44
precoopera: giredestrant versus anastrozole in er /her2- early breast cancer
-
2:01
α-actinin network in human ipsc-derived cardiomyocytes l protocol preview
-
1:16
elderly in berlin given covid vaccinations
-
2:01
pattern-based search of epigenomic data using genemo l protocol preview
-
3:12
treatment of pancreatic cancer: overview of the continued progress